Articles
Donald Trump Initiates $5 Billion Lawsuit Against JPMorgan Chase and CEO Jamie Dimon Over Account Closures
Former President Claims Banking Relationship Severed Due to Political Bias Following Capitol Riot
Donald Trump has launched a $5 billion civil lawsuit against JPMorgan Chase and its CEO Jamie Dimon, asserting that the bank terminated accounts linke...
O-I Glass: Fit‑To‑Win Momentum — Buy for a Multi‑Year Rebound (Actionable Trade)
Operational cash flow and sustainability investments create a path to durable margin improvement despite leverage - tactical entry, disciplined stop, multi-year upside targets.
O-I Glass is showing the early stages of a turnaround: positive net income in the latest quarter, strong operating cash flow, and targeted investments...
Community Health Systems: A Risk-Weighted Buy Into 2026’s Distressed Yield Story
Why I’m keeping a risky Buy on CYH — small market cap, big revenues, heavy leverage, and a path to outsized upside if execution and balance-sheet fixes hold.
Community Health Systems (CYH) is a high-volatility, high-reward trade in early 2026. The company generates ~3.1 billion in quarterly revenue and posi...
Ruger in 2026: A Short-Term, Catalyst-Driven 'In & Out' Swing Trade
Use pullbacks to buy, respect volatility - clear entries, stops and targets for a nimble trade
Sturm, Ruger & Co. (RGR) is a cash-generative, low-debt firearm manufacturer with a patchy recent earnings run and an active capital-return program. T...
Alphabet's Shares Advance Following Upgraded Forecast on Google Cloud and AI Prospects
Analyst Optimism Surrounds Google's Cloud Growth and AI Initiatives Amid Steady Stock Momentum
Alphabet Inc.'s stock experiences upward movement driven by optimistic analyst revisions focused on Google's Cloud Platform and artificial intelligenc...
Applied Digital at an Inflexion Point - Buy the AI Infrastructure Story, but Size Carefully
Strong revenue acceleration and a multi-billion capital raise fuel a growth story — execution and dilution risks make this a high-risk, high-reward position.
Applied Digital (APLD) has pivoted into AI/HPC infrastructure and just reported a step-up quarter: revenue of $126.6M (quarter ended 11/30/2025) with ...
Teradyne: Two Megatrends - AI Compute and Factory Automation - Back a Tactical Long Into Earnings
Earnings preview and a concrete trade: play TER for upside from AI-driven test demand and continued robotics growth, with strict risk controls
Teradyne sits at the intersection of semiconductor test equipment and industrial robotics. With Q3 2025 results showing resilient margins (gross profi...
15 Dow Jones Stocks Positioned to Increase Dividends in 2026: An Analysis
Examining the Stability and Growth Prospects of Key Industrial Average Dividend Payers
The Dow Jones Industrial Average comprises 30 components that have historically offered reliable dividend returns. In 2025, 15 of these stocks raised ...
Visa Enhances Crypto-to-Fiat Transactions Through Partnership with Mercuryo
Collaboration with Mercuryo aims to streamline real-time digital asset conversions on Visa cards globally
Visa has teamed up with the international payments provider Mercuryo to facilitate quick and cost-effective conversion of cryptocurrency holdings into...
Analyst Highlights Technical Setbacks and Political Influences Affecting Bitcoin and Major Altcoins
Market Momentum Disrupted Amid Geopolitical Uncertainty and Technical Resistance Challenges
Bitcoin's recent recovery effort has faltered after failing to surpass key resistance levels, with political developments amplifying market volatility...
Jim Cramer Counters Claims That Political Climate Deters Stock Market Investing
CNBC Host Highlights Market Opportunities Despite Volatility Under Current Administration
Jim Cramer, host of CNBC's 'Mad Money,' has publicly disputed assertions that President Donald Trump's policies and rhetoric are driving investors awa...
Janux Therapeutics Enters $800 Million Collaboration Deal with Bristol Myers Squibb
San Diego-based Janux licenses immunotherapy platform to BMS, advancing clinical development in solid tumors
Janux Therapeutics has formed an exclusive worldwide collaboration and license agreement with Bristol Myers Squibb focused on the development of tumor...